CanSino Biologics Inc. (OTCMKTS:CASBF) Sees Significant Growth in Short Interest

CanSino Biologics Inc. (OTCMKTS:CASBF) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 414,600 shares, a growth of 3,601.8% from the February 28th total of 11,200 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 4,146.0 days.

CanSino Biologics Price Performance

CanSino Biologics stock remained flat at C$4.60 during mid-day trading on Thursday. The company had a trading volume of 45 shares, compared to its average volume of 929. The firm’s 50 day moving average is C$3.94 and its 200-day moving average is C$3.68. CanSino Biologics has a fifty-two week low of C$1.86 and a fifty-two week high of C$4.90.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.